Synergy between extracellular group IIA phospholipase A2 and phagocyte NADPH oxidase in digestion of phospholipids of Staphylococcus aureus ingested by human neutrophils

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4653-4661

  Femling, Jon K ^a,b   Nauseef, William M ^a,b   Weiss, Jerrold P ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Inflammation Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE; OXYGEN; PHOSPHOLIPASE A2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CATALYSIS; CELL INVASION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; NEUTROPHIL; PHAGOCYTOSIS; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 25444465641     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.7.4653     Document Type: Article

References (68)

1. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
2. Peacock, S. J., I. de Silva, and F. D. Lowy. 2001. What determines nasal carriage of Staphylococcus aureus? Trends Microbiol. 9: 605-610.
3. 2. J. Clin. Invest. 102: 633-638.
4. Lekstrom-Himes, J. A., and J. I. Gallin. 2000. Immunodeficiency diseases caused by defects in phagocytes. N. Engl. J. Med. 343: 1703-1714.
5. Lee, W. L., R. E. Harrison, and S. Grinstein. 2003. Phagocytosis by neutrophils. Microbes. Infect. 5: 1299-1306.
6. Verbrugh, H. A., P. K. Peterson, B. Y. Nguyen, S. P. Sisson, and Y. Kim. 1982. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J. Immunol. 129: 1681-1687.
7. Cunnion, K. M., H. M. Zhang, and M. M. Frank. 2003. Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis. Infect. Immun. 71: 656-662.
8. Borregaard, N., and J. B. Cowland. 1997. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503-3521.
9. Nauseef, W. M. 2004. Assembly of the phagocyte NADPH oxidase. Histochem. Cell Biol. 122: 277-291.
10. Nauseef, W. M. 1999. The NADPH-dependent oxidase of phagocytes. Proc. Assoc. Am. Physicians 111: 373-382.
11. Segal, A. W., A. M. Harper, R. C. Garcia, and D. Merzbach. 1982. The action of cells from patients with chronic granulomatous disease on Staphylococcus aureus. J. Med. Microbiol. 15: 441-449.
12. Hampton, M. B., A. J. Kettle, and C. C. Winterbourn. 1998. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92: 3007-3017.
13. + flux. Nature 416: 291-297.
14. Harrison, R. E., N. Touret, and S. Grinstein. 2002. Microbial killing: oxidants, proteases and ions. Curr. Biol. 12: R357-R359.
15. Fang, F. C. 1997. Perspectives series: host/pathogen interactions: mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99: 2818-2825.
16. Weiss, J., L. Kao, M. Victor, and P. Elsbach. 1987. Respiratory burst facilitates the digestion of Escherichia coli killed by polymorphonuclear leukocytes. Infect. Immun. 55: 2142-2147.
17. 2 enzymes. Prostaglandins Other Lipid Mediat. 68-69: 3-58.
18. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488: 1-19.
19. 2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J. Biol. Chem. 277: 1788-1793.
20. 2. J. Clin. Invest. 97: 250-257.
21. 2 acting against Escherichia coli. Infect. Immun. 64: 2425-2430.
22. Elsbach, P., J. Weiss, and O. Levy. 1994. Integration of antimicrobial host defenses: role of the bactericidal/permeability-increasing protein. Trends Microbiol. 2: 324-328.
23. 2 in inflammatory diseases and trauma. Biochim. Biophys. Acta 1488: 83-90.
24. 2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect. Immun. 66: 2791-2797.
25. 2 to Escherichia coli infection. Infect. Immun. 68: 87-92.
26. 2 against Staphylococcus aureus. J. Immunol. 162: 7402-7408.
27. 2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J. Biol. Chem. 277: 5061-5073.
28. 2 against gram-positive bacteria. Doctoral dissertation, New York University, New York, NY.
29. 2 against grossly clumped Staphylococcus aureus. Infect. Immun. 67: 2299-2305.
30. 2 in concert with polymorphonuclear leukocytes. J. Biol. Chem. 269: 26331-26337.
31. 2 against Staphylococcus aureus. J. Biol. Chem. 277: 47636-47644.
32. Cheung, A. L., C. C. Nast, and A. S. Bayer. 1998. Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model. Infect. Immun. 66: 5988-5993.
33. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 97(Suppl.): 77-89.
34. Iovine, N. M., P. Elsbach, and J. Weiss. 1997. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc. Natl. Acad. Sci. USA 94: 10973-10978.
35. 2. Infect. Immun. 68: 1259-1264.
36. Hayami, M., A. Okabe, R. Kariyama, M. Abe, and Y. Kanemasa. 1979. Lipid composition of Staphylococcus aureus and its derived L-forms. Microbiol. Immunol. 23: 435-442.
37. Short, S. A., and D. C. White. 1972. Biosynthesis of cardiolipin from phosphatidylglycerol in Staphylococcus aureus. J. Bacteriol. 109: 820-826.
38. 2α activity that is responsible for arachidonic acid release. J. Biol. Chem. 278: 24153-24163.
39. 2. Biol. Pharm. Bull. 27: 1158-1164.
40. 2 in murine bone marrow-derived mast cells. J. Immunol. 165: 2773-2782.
41. Cross, A. R., and O. T. Jones. 1986. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils: specific labelling of a component polypeptide of the oxidase. Biochem. J. 237: 111-116.
42. Klebanoff, S. J. 1999. Myeloperoxidase. Proc. Assoc. Am. Physicians 111: 383-384.
43. Ohno, Y., and J. I. Gallin. 1985. Diffusion of extracellular hydrogen peroxide into intracellular compartments of human neutrophils: studies utilizing the inactivation of myeloperoxidase by hydrogen peroxide and azide. J. Biol. Chem. 260: 8438-8446.
44. Weinrauch, Y., A. Foreman, C. Shu, K. Zarember, O. Levy, P. Elsbach, and J. Weiss. 1995. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J. Clin. Invest. 95: 1916-1924.
45. Chapman, A. L., M. B. Hampton, R. Senthilmohan, C. C. Winterbourn, and A. J. Kettle. 2002. Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J. Biol. Chem. 277: 9757-9762.
46. Gresham, H. D., J. H. Lowrance, T. E. Caver, B. S. Wilson, A. L. Cheung, and F. P. Lindberg. 2000. Survival of Staphylococcus aureus inside neutrophils contributes to-infection. J. Immunol 164: 3713-3722.
47. Mandell, G. L. 1975. Catalase, superoxide dismutase, and virulence of Staphylococcus aureus: in vitro and in vivo studies with emphasis on staphylococcal-leukocyte interaction. J. Clin. Invest. 55: 561-566.
48. Wright, G. C., J. Weiss, K. S. Kim, H. Verheij, and P. Elsbach. 1990. Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils: role of cellular and extracellular phospholipases. J. Clin. Invest. 85: 1925-1935.
49. Koch, H. U., R. Haas, and W. Fischer. 1984. The role of lipoteichoic acid biosynthesis in membrane lipid metabolism of growing Staphylococcus aureus. Eur. J. Biochem. 138: 357-363.
50. 2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J. Biol. Chem. 265: 6675-6681.
51. 2 purified from an inflammatory exudate. Biochemistry 25: 8381-8385.
52. 2. J. Biol. Chem. 277: 5849-5857.
53. 2. Biochim. Biophys. Acta 1488: 48-58.
54. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275: 3179-3191.
55. Sohlenkamp, C., I. M. Lopez-Lara, and O. Geiger. 2003. Biosynthesis of phosphatidylcholine in bacteria. Prog. Lipid Res. 42: 115-162.
56. 2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J. Biol. Chem. 271: 30041-30051.
57. 2 receptor on neutrophils and its role in elastase release and adhesion. Am. J. Physiol. Cell Physiol 283: C1102-C1113.
58. 2 in mast cells. Biochem. Biophys. Res. Commun. 276: 667-672.
59. Hubbard, R. C., F. Ogushi, G. A. Fells, A. M. Cantin, S. Jallat, M. Courtney, and R. G. Crystal. 1987. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of α1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Invest. 80: 1289-1295.
60. 2 in granules and secrete active enzyme in response to soluble stimuli. Biochem. Biophys. Res. Commun. 208: 650-656.
61. Melly, M. A., J. B. Thomison, and D. E. Rogers. 1960. Fate of staphylococci within human leukocytes. J. Exp. Med. 112: 1121-1130.
62. 2. Biochim. Biophys. Acta 1488: 71-82.
63. Clements, M. O., and S. J. Foster. 1999. Stress resistance in Staphylococcus aureus. Trends Microbiol. 7: 458-462.
64. Catucci, L., N. Depalo, V. M. Lattanzio, A. Agostiano, and A. Corcelli. 2004. Neosynthesis of cardiolipin in Rhodobacter sphaeroides under osmotic stress. Biochemistry 43: 15066-15072.
65. Voyich, J. M., K. R. Braughton, D. E. Sturdevant, C. Vuong, S. D. Kobayashi, S. F. Porcella, M. Otto, J. M. Musser, and F. R. DeLeo. 2004. Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense. J. Immunol. 173: 1194-1201.
66. Sillevis Smitt, J. H., J. D. Bos, R. S. Weening, and S. R. Krieg. 1990. Discoid lupus erythematosus-like skin changes in patients with autosomal recessive chronic granulomatous disease. Arch. Dermatol. 126: 1656-1658.
67. Rupec, R. A., T. Petropoulou, B. H. Belohradsky, M. Walchner, J. G. Liese, G. Plewing, and G. Messer. 2000. Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. Eur. J. Dermatol. 10: 184-189.
68. Koskenmies, S., O. Vaarala, E. Widen, J. Kere, T. Palosuo, and H. Julkunen. 2004. The association of antibodies to cardiolipin, β2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Scand. J. Rheumatol. 33: 246-252.